Form 4: Centene Director Christopher Coughlin Reports Share Transactions
SEC Form 4 Filing
Director Christopher Coughlin reported acquiring 497 shares of Centene stock and transferring 30,054 shares to a grantor retained annuity trust.
Summary
- Christopher Coughlin, a director at Centene Corp, reported a transaction on December 31, 2024.
- He acquired 497 shares of common stock at a price of $0.
- He also transferred 30,054 shares of common stock to a grantor retained annuity trust on December 23, 2024.
- Mr. Coughlin is the sole trustee of this trust.
- The report also notes that Mr. Coughlin holds options to purchase 10,000 shares of common stock at an exercise price of $80.57, exercisable from February 7, 2025, to February 7, 2032.
- The ownership includes 2,916 shares of restricted stock units subject to vesting requirements.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of insider transactions, which is neither positive nor negative in itself. It is a neutral event.
Industry Context
This is a standard SEC Form 4 filing, which is a routine disclosure of transactions by company insiders. It provides transparency into the trading activities of company directors.
Comparison to Industry Standards
- SEC Form 4 filings are a standard practice for publicly traded companies, and this filing is consistent with those requirements.
- The transactions reported are typical for directors, including stock option grants and transfers to trusts for estate planning purposes.
- Comparable companies would have similar filings when their directors or officers engage in stock transactions.
Stakeholder Impact
- The transactions reported in this filing provide transparency to shareholders regarding the trading activities of a company director.
- The transfer of shares to a trust may have implications for the director's long-term holdings and estate planning.
Key Dates
| Date | Description |
|---|---|
| 12/23/2024 | Mr. Coughlin contributed 30,054 shares of common stock to a grantor retained annuity trust. |
| 12/31/2024 | Mr. Coughlin acquired 497 shares of common stock. |
| 02/07/2025 | Date from which Mr. Coughlin's stock options become exercisable. |
| 02/07/2032 | Expiration date of Mr. Coughlin's stock options. |
| 01/03/2025 | Date the SEC Form 4 was signed. |
Keywords
Centene, CNC, Director, Christopher Coughlin, Share Transaction, Grantor Retained Annuity Trust, Stock Options, Restricted Stock Units, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.